文献速递外周动脉疾病

跛行患者活动性吸烟不影响血管内干预结局

Active Tobacco Use in Patients with Claudication Does Not Affect Outcomes after Endovascular Interventions.
PubMed 文献 · Ann Vasc Surg · 2019-05-17

中位随访3.6年,两组再干预、外科旁路、截肢、心肌梗死、卒中及死亡发生率均无统计学显著差异。结论认为不应仅因患者无法戒烟而拒绝血管内干预,但样本量小需更大研究证实。

要点

  • 活动性吸烟未显著增加跛行患者血管内治疗后再干预、截肢或死亡风险。
  • 不应仅因持续吸烟而拒绝为跛行患者提供血管内干预。
  • 仍需强烈建议所有吸烟患者戒烟。

核心结论

  • 活动性吸烟不增加跛行患者血管内干预后再干预、转为开放手术、截肢或其他并发症的风险。
  • 不应因患者无法戒烟而拒绝其接受血管内干预的潜在获益。

研究设计与样本

  • 回顾性病历 review,2007至2011年于中型社区教学医院开展。
  • 纳入138例有记录的的生活方式受限性跛行、首次接受血管内治疗的患者。

主要发现

  • 两组平均年龄66.34岁(标准差10.7),无统计学差异。
  • 平均随访3.6年,两组间无显著差异。
  • 活动性吸烟组与非吸烟组在再干预率、外科旁路率及截肢率上无统计学显著差异。
  • 两组心肌梗死、卒中及死亡发生率在随访期间亦无显著差异。

临床怎么用

  • 对于因跛行考虑血管内干预的患者,持续吸烟不应作为绝对排除标准。
  • 仍应强烈建议所有吸烟患者戒烟。

局限性

  • 研究最重要的局限性为可 review 的患者数量少。
  • 需要更大规模研究证实本研究发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: With the advent of endovascular procedures, the indications for intervention in claudicants have become less strict. Many interventionalists, however, will not intervene in patients with lifestyle-limiting claudication unless they have discontinued tobacco use. Many patients are unable to comply with this goal, and there is little published evidence to suggest that continued tobacco use results in poorer outcomes. We sought to determine if it is justified to deny this group of patients endovascular, potentially lifestyle-improving, procedures based on their outcomes. METHODS: A retrospective chart review was performed between 2007 and 2011 at a midsize community teaching hospital. Patients included had documented lifestyle-limiting claudication, underwent endovascular therapy, and had no previous vascular intervention. Patients were divided into 2 groups: active smokers (AS) and nonsmokers (NS) including former and never smokers. The primary outcome was the need for reintervention and the secondary outcomes were the need for surgical revascularization, limb loss, myocardial infarction (MI), stroke, and death. RESULTS: One hundred thirty-eight patients met inclusion criteria with 89 being male (64.5%). Forty-seven (34%) were active smokers versus 91 (66%) who were nonsmokers. Mean age at initial intervention for all 138 subjects was 66.34 years (standard deviation 10.7) and was not statistically different between the AS and NS groups. Mean follow-up was 3.6 years and was not significantly different between the two groups. Between the two groups (AS vs NS), there was no statistically significant difference between the rate of reintervention, surgical bypass, and limb loss. We also did not observe any significant difference in the rate of MI, stroke, or death during our follow-up period. CONCLUSIONS: Although tobacco use has been shown to negatively impact bypass patency, our data show that it does not appear to increase the need for reintervention, conversion to open surgical revascularization, limb loss, or other morbidities in patients undergoing endovascular interventions for claudication. We continue to strongly recommend all our patients who smoke to discontinue tobacco use. Our results, however, do not support the notion that those patients who are unable to quit should be denied the potential benefit of an endovascular intervention. The most important limitation of our study is the small numbers of patients available for review. Larger studies will be necessary to confirm our findings.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Schlieder I, Richard M, Nacar A, et al. Active Tobacco Use in Patients with Claudication Does Not Affect Outcomes after Endovascular Interventions. Ann Vasc Surg. 2019. PMID: 31103674. doi:10.1016/j.avsg.2019.02.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。